New York, January 7, 2026, 04:55 ET — Premarket
- Shares rose 4.6% to close on Tuesday and were last up about 0.4% after hours.
- Evercore ISI lifted its price target on Intuitive Surgical while keeping a neutral-leaning rating.
- Next catalysts: a Jan. 14 J.P. Morgan Healthcare Conference webcast and the company’s Jan. 22 quarterly earnings call.
Intuitive Surgical, Inc. (ISRG.O) shares rose 4.6% to close at $592.85 on Tuesday and were last up about 0.4% in after-hours trading.
The move matters now because January is a key checkpoint for medical device stocks, with investors looking for early-year signals on hospital spending and procedure demand. For Intuitive, even small changes in tone around system placements and recurring instrument sales can quickly shift expectations.
The stock is near the top of its 52-week range and carries a rich valuation, which can amplify swings around news. Nasdaq data show ISRG’s 52-week range is roughly $425 to $616 and the shares trade at about 77 times earnings.
Trading in the latest session was heavy, with about 2.63 million shares changing hands. The stock traded between $564.35 and $594.62 on Tuesday, closing near the top of the day’s range.
Evercore ISI on Tuesday raised its price target on Intuitive Surgical to $580 from $540 and kept an “In Line” rating. The firm pointed to “healthy procedure and CapEx trends” — capital spending by hospitals — while flagging policy uncertainty as a risk factor. TipRanks
The company’s next two scheduled events are close. Intuitive is set to present at the 44th Annual J.P. Morgan Healthcare Conference on Jan. 14 and hold its Q4 2025 earnings conference call on Jan. 22, according to its investor site.
Between now and then, traders will parse any read-through on procedure volume — the number of surgeries done using its systems — and demand for high-margin instruments and accessories. Investors also tend to focus on commentary around hospital budgets and any changes to the pace of new system placements.
Macro data could also steer sentiment in the near term. The U.S. calendar includes the ADP private payrolls report and S&P Global’s final services PMI reading on Wednesday, with the government’s December 2025 employment report scheduled for Friday, Jan. 9.
But the upside case has a clear vulnerability: valuation. If management commentary or near-term data suggest slower procedure growth, tighter hospital budgets, or margin pressure, ISRG can reprice quickly because investors pay up for steady growth.
Related articles: NASDAQ:ISRG
